Guard Therapeutics announced that the company has appointed Torbjörn Larsson as Head of CMC (Chemistry, Manufacturing and Controls). Torbjörn Larsson will join the management team and will report directly to the CEO. Torbjörn Larsson has over 30 years of experience in the life science industry, including from roles as Director Pharmaceutical R&D at Medivir, Director of CMC at OxyPharma, and several positions within Pharmacia and Kabi.

Torbjörn studied chemistry and biotechnology at Uppsala University and comes most recently from Aprea Therapeutics as Director Commercial Production in the CMC area. Torbjörn Larsson will take up the position on 1 May 2022 and succeed Lars Olsson, who will continue to assist the company with his expertise for some time to come.